España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Mirum Pharmaceuticals
MIRM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$42.65
0.26
0.61%
At close: -
$42.65
0.00
0.00%
After Hours: 4:01 PM EDT
Get Report
Comment
Mirum Pharmaceuticals (MIRM) Forecast
News
Earnings
Mirum Pharmaceuticals (MIRM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock
Mirum Pharmaceuticals Stock (NASDAQ: MIRM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
Mirum Pharmaceuticals To Showcase Data From I...
Benzinga Newsdesk
Wednesday, November 13, 2024
Breaking Down Mirum Pharmaceuticals: 5 Analysts Share Their Views
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Mirum P...
Benzinga Newsdesk
Citigroup Maintains Buy on Mirum Pharmaceutic...
Benzinga Newsdesk
Baird Maintains Outperform on Mirum Pharmaceu...
Benzinga Newsdesk
Tuesday, November 12, 2024
Mirum Pharmaceuticals Q3 2024 GAAP EPS $(0.30...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Earnings Outlook For Mirum Pharmaceuticals
Benzinga Insights
Thursday, October 31, 2024
Mirum Pharmaceuticals To Showcase LIVMARLI Da...
Benzinga Newsdesk
Friday, October 11, 2024
Analyst Expectations For Mirum Pharmaceuticals's Future
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Mirum P...
Benzinga Newsdesk
Thursday, October 10, 2024
Mirum Pharmaceuticals Announces The FDA Has G...
Benzinga Newsdesk
Tuesday, September 17, 2024
Is First Trust Small Cap Growth AlphaDEX ETF a Strong ETF Right Now?
Zacks
Thursday, September 12, 2024
Should First Trust Small Cap Growth AlphaDEX ETF Be on Your Investing Radar?
Zacks
Tuesday, August 20, 2024
Mirum Banks on Livmarli, Overdependence a Concern
Zacks
Thursday, August 08, 2024
Cantor Fitzgerald Maintains Overweight on Mir...
Benzinga Newsdesk
Evercore ISI Group Maintains Outperform on Mi...
Benzinga Newsdesk
Baird Maintains Outperform on Mirum Pharmaceu...
Benzinga Newsdesk
Wednesday, August 07, 2024
Mirum Pharmaceuticals On Track To Achieve FY2...
Benzinga Newsdesk
Mirum Pharmaceuticals Q2 2024 GAAP EPS $(0.52...
Benzinga Newsdesk
Friday, July 26, 2024
Watching Mirum Pharmaceuticals; Shares Tradin...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Mirum P...
Benzinga Newsdesk
Thursday, July 25, 2024
Mirum's LIVMARLI Now Approved For Progressive...
Benzinga Newsdesk
Wednesday, July 10, 2024
Janus Henderson Group Discloses 10.6% Passive...
Benzinga Newsdesk
Monday, July 08, 2024
HC Wainwright & Co. Reiterates Buy on Mirum P...
Benzinga Newsdesk
Mirum Pharmaceuticals' LIVMARLI Approved In T...
Benzinga Newsdesk
Friday, June 28, 2024
HC Wainwright & Co. Reiterates Buy on Mirum P...
Benzinga Newsdesk
Mirum Submits New Drug Application To FDA For...
Benzinga Newsdesk
Thursday, June 20, 2024
Stifel Maintains Buy on Mirum Pharmaceuticals...
Benzinga Newsdesk
Tuesday, June 18, 2024
Citigroup Maintains Buy on Mirum Pharmaceutic...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Mirum Pharm...
Benzinga Newsdesk
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Morgan Stanley Maintains Overweight on Mirum ...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Monday, June 17, 2024
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Mirum Ph...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Stifel Reiterates Buy on Mirum Pharmaceutical...
Benzinga Newsdesk
Baird Maintains Outperform on Mirum Pharmaceu...
Benzinga Newsdesk
Mirum Pharmaceuticals Highlights Encouraging Data For Rare Liver Disease Therapy From Two Mid-Stage Studies
Vandana Singh
Mirum Pharmaceuticals shares are trading high...
Benzinga Newsdesk
Aaron's, Mirum Pharmaceuticals, Primo Water And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Mirum's Volixibat Achieves Interim Analyses I...
Benzinga Newsdesk
Friday, June 07, 2024
HC Wainwright & Co. Reiterates Buy on Mirum P...
Benzinga Newsdesk
Thursday, June 06, 2024
Mirum Pharmaceuticals Presents Long-Term Data...
Benzinga Newsdesk
Monday, June 03, 2024
HC Wainwright & Co. Reiterates Buy on Mirum P...
Benzinga Newsdesk
Friday, May 31, 2024
Mirum Pharmaceuticals Gets Positive CHMP Opin...
Benzinga Newsdesk
Wednesday, May 29, 2024
Mirum Pharmaceuticals To Present Long-Term Da...
Benzinga Newsdesk
Monday, May 20, 2024
Reported Saturday, Mirum Pharmaceuticals' LIV...
Benzinga Newsdesk
Friday, May 10, 2024
Morgan Stanley Maintains Overweight on Mirum ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch